Paper · 42490959
Transfer RNA expression, modification, and derived small RNAs in cancer biology and clinical potential.
Luo M and 8 others. Front Immunol, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Transfer RNA expression, modification, and derived small RNAs in cancer biology and clinical potential. Papers, record 42490959. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42490959
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Transfer RNA expression, modification, and derived small RNAs in cancer biology and clinical potential.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| RNA, Transfer | Major topic |
| Neoplasms | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| RNA, Small Untranslated | Major topic |
| Humans | |
| Animals | |
| Amino Acyl-tRNA Synthetases | |
| RNA Processing, Post-Transcriptional | |
| Biomarkers, Tumor |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References162
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,965,412 | Targeting N7-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. | Mol Ther | 2023 | https://conductscience.org/library/papers/35965412 | PubMed |
| 2 | 35,681,060 | tRNA dysregulation and disease. | Nat Rev Genet | 2022 | https://conductscience.org/library/papers/35681060 | PubMed |
| 3 | 40,461,825 | TRMT6-mediated tRNA m1A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression. | Nat Cancer | 2025 | https://conductscience.org/library/papers/40461825 | PubMed |
| 4 | 36,527,118 | A novel tRNA-derived fragment tRF-3022b modulates cell apoptosis and M2 macrophage polarization via binding to cytokines in colorectal cancer. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/36527118 | PubMed |
| 5 | 37,660,182 | N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer. | Oncogene | 2023 | https://conductscience.org/library/papers/37660182 | PubMed |
| 6 | 37,516,825 | METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37516825 | PubMed |
| 7 | 39,737,343 | Advancements in pseudouridine modifying enzyme and cancer. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39737343 | PubMed |
| 8 | 39,806,419 | tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer. | J Transl Med | 2025 | https://conductscience.org/library/papers/39806419 | PubMed |
| 9 | 40,726,981 | tRNA-derived small RNA 3' tRF-Ala CGC obstructs NK cytotoxicity via cleavage of membrane protein MICA in colorectal cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/40726981 | PubMed |
| 10 | 37,259,935 | Dysregulation of Transfer RNA-derived Small RNAs that Regulate Cell Activity and its Related Signaling Pathways in Human Cancers. | Curr Gene Ther | 2023 | https://conductscience.org/library/papers/37259935 | PubMed |
1 to 10 of 162
See all 162 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,943,257 | Mechanisms and Therapeutic Advances of Natural Products Regulating Non-Coding RNAs in Cancer. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943257 |
Source PubMed
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42490959
GET https://conductscience.org/api/papers/v1/42490959/references?page=2